New study investigates cholesterol side effect of diabetes drug
NCT ID NCT03269058
First seen Mar 21, 2026 · Last updated May 01, 2026 · Updated 4 times
Summary
This study aims to understand why dapagliflozin, a diabetes medication, can increase bad cholesterol levels. Researchers will track how the body produces and removes cholesterol in 28 adults with type 2 diabetes over 6 months. Half will receive the drug, half a placebo. The results may help doctors choose better cholesterol treatments for these patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU Dijon Bourgogne
Dijon, 21079, France
Conditions
Explore the condition pages connected to this study.